NKCx Histopathological outcome* within 12 months after cervix cytology in 2021 |
521 Borås |
Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
Benign sample | 302 | 3.2% | 27 | 0.3% | 8 | 0.1% | . | . | 1 | 0.0% | 7 | 0.1% | 9147 | 96.4% | 9492 | 100.0% |
ASCUS | 386 | 23.4% | 156 | 9.5% | 46 | 2.8% | 1 | 0.1% | 1 | 0.1% | 12 | 0.7% | 1047 | 63.5% | 1649 | 100.0% |
LSIL | 139 | 25.2% | 130 | 23.6% | 54 | 9.8% | . | . | . | . | 4 | 0.7% | 225 | 40.8% | 552 | 100.0% |
Atypical glandular cells/AGC | 21 | 43.8% | . | . | 4 | 8.3% | 1 | 2.1% | 3 | 6.3% | . | . | 19 | 39.6% | 48 | 100.0% |
Unclear atypia | 1 | 50.0% | . | . | . | . | . | . | . | . | . | . | 1 | 50.0% | 2 | 100.0% |
ASC-H | 31 | 23.5% | 26 | 19.7% | 62 | 47.0% | . | . | 1 | 0.8% | . | . | 12 | 9.1% | 132 | 100.0% |
HSIL | 11 | 5.2% | 19 | 9.0% | 161 | 75.9% | 4 | 1.9% | 8 | 3.8% | . | . | 9 | 4.2% | 212 | 100.0% |
Suspected Adenocarcinom | 2 | 25.0% | 1 | 12.5% | . | . | . | . | 2 | 25.0% | . | . | 3 | 37.5% | 8 | 100.0% |
Malignant tumor with unclear origin | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | 1 | 100.0% |
Squamous cell cancer | 1 | 20.0% | . | . | 1 | 20.0% | . | . | 3 | 60.0% | . | . | . | . | 5 | 100.0% |
Totalt | 894 | 7.4% | 359 | 3.0% | 336 | 2.8% | 6 | 0.0% | 20 | 0.2% | 23 | 0.2% | 10463 | 86.5% | 12101 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80413, M80703, M81403, M82003, M83803, M84006, M84603 |